Physicians should encourage pharmaceutical companies to make socially responsible funding decisions and take an active role in setting biomedical research priorities by advocating for fair and effective allocations of public and private biomedical R & D investments.
A Canadian physician reports there is systematic bias to the outcome of published research funded by the pharmaceutical industry and believes more steps need to be taken to improve the integrity of clinical research reports in the United States and Canada.
Professor Richard L. Cupp Jr joins Ethics Talk to discuss his article: “How Might Corporations’ and Nonhuman Animals’ Personhood Compare Under the Fifth and Fourteenth Amendments?”
Whether and to what extent constitutional equal protection should apply to some nonhuman animals can be considered in light of corporations having gained such protection.
AMA J Ethics. 2024; 26(9):E690-695. doi:
10.1001/amajethics.2024.690.
Grayson Holt joins Ethics Talk to discuss his article, coauthored with Dr Johanna Glaser: “Why Is Hospice One of the Few Health Care Environments Structured for Peace?”